4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-017751
Director sold 29,256 shares at an average $27.89 ($815,863)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHAFFER DAVID Director | 2021-09-29 | Sale | −7,806 | $27.99 | $218,512 | 958,950 | D |
| SCHAFFER DAVID Director | 2021-09-29 | Sale | −8,365 | $29.06 | $243,058 | 950,585 | D |
| SCHAFFER DAVID Director | 2021-09-29 | Sale | −700 | $30.06 | $21,044 | 949,885 | D |
| SCHAFFER DAVID Director | 2021-09-30 | Sale | −7,836 | $26.69 | $209,165 | 942,049 | D |
| SCHAFFER DAVID Director | 2021-09-30 | Sale | −4,549 | $27.28 | $124,085 | 937,500 | D |
| Open-market sales · 29,256 sh · avg $27.89 · $815,863 | |||||||
Loading xslF345X03/doc1.xml…